Attached files
| file | filename |
|---|---|
| EX-4.3 - EXHIBIT 4.3 - Emmaus Life Sciences, Inc. | s108528_ex4-3.htm |
| 10-K - 10-K - Emmaus Life Sciences, Inc. | s108528_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - Emmaus Life Sciences, Inc. | s108528_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Emmaus Life Sciences, Inc. | s108528_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Emmaus Life Sciences, Inc. | s108528_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Emmaus Life Sciences, Inc. | s108528_ex31-1.htm |
| EX-23.2 - EXHIBIT 23.2 - Emmaus Life Sciences, Inc. | s108528_ex23-2.htm |
| EX-23.1 - EXHIBIT 23.1 - Emmaus Life Sciences, Inc. | s108528_ex23-1.htm |
Exhibit 21.1
MYnd Analytics, Inc., a California corporation (formerly called CNS Response, Inc. until November 22, 2017), Colorado CNS Response, Inc., a Colorado corporation and Arcadian Telepsychiatry Services LLC, a Delaware limited liability company, are wholly-owned subsidiaries of MYnd Analytics, Inc., a Delaware corporation.
Neuro-Therapy Clinic, Inc., a Colorado corporation, is a wholly-owned subsidiary of Colorado CNS Response, Inc.